Found 14 matching trials
Study of the Combination of CM082 With Everolimus in Patients With mRCC
PHASE1This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerabilit...
Location
Beijing Cancer Hospital
CM082 in Patients With Myopic Choroidal Neovascularization (CNV)
PHASE1This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Location
Peking Union Medical College Hospital
Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.
PHASE2This study was a one-arm, single-center, phase II clinical study. Patients ...
Location
Beijing Cancer Hospital
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
PHASE1This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Location
Shanghai East Hospital
Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China
PHASE1This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerabilit...
Location
Beijing University First Hospital
Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer
PHASE1This is an open-label, Phase 1b study which will be conducted in two parts:...
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Bioequivalency Study of CM082 Tablet in Healthy Volunteers
PHASE1The main objective of this study is to evaluate the bioequivalency of two p...
Location
The 1st Phase Clinical Research Center of the Second Affiliated Hospital of Zhejiang University Medical College
Phase 1 Study of CM082 in Patients With wAMD
PHASE1This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerabilit...
Location
Peking University People's Hospital
A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers
PHASE1The main objective of this study is to evaluate the Effect of Food on the P...
Location
The 1st Phase Clinical Research Center of the Second Affiliated Hospital of Zhejiang University Medical College
CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).
PHASE2This study was a one-arm, single-center, phase II clinical study. Patients ...
Location
Beijing Cancer Hospital